ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
-1.03%
Bitcoin
62,844.18
6.30%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) Noticias

VOR Vor Biopharma Inc

1.80
0.04 (2.27%)
Fuera de horario
Última actualización: 17:00:01
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Vor Biopharma Inc VOR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.04 2.27% 1.80 17:00:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.81 1.76 1.84 1.80 1.76
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02/5/202415:01GLOBEVor Bio Appoints Accomplished Oncology and Cancer..
01/4/202407:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
20/3/202415:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
04/3/202407:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
14/2/202415:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202407:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
02/2/202415:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
31/1/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:01GLOBEVor Bio Doses First AML Patient with VCAR33 (ALLO) and..
05/1/202416:03EDGAR2Form 8-K - Current report
21/12/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
27/11/202307:00GLOBEVor Bio to Participate in the JMP Securities Hematology and..
09/11/202315:01GLOBEVor Bio Presents Positive Data Update on Trem-cel at HSCT²..
08/11/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:05GLOBEVor Bio Reports Third Quarter 2023 Financial Results and..
07/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
03/11/202307:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
02/11/202308:10EDGAR2Form 8-K - Current report
02/11/202308:01GLOBEMultiple Clinical and Preclinical Presentations at ASH..
03/10/202315:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
25/9/202307:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
06/9/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/8/202307:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
10/8/202315:05GLOBEVor Bio Reports Second Quarter 2023 Financial Results and..
10/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202307:00GLOBEVor Bio to Participate in the Wedbush PacGrow Healthcare..
09/6/202306:30GLOBESuccessful Primary Engraftment of Trem-cel in First Five AML..
05/6/202307:00GLOBEVor Bio to Participate in the Goldman Sachs Healthcare..
11/5/202315:05GLOBEVor Bio Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

NASDAQ
VOR
Vor Biopharma
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados